Answers are grounded in this paper and cite their sources.
Precision cancer therapy involves the clinical diagnosis of the molecular characteristics of cancer and thereby designing appropriate therapeutic strategy to treat the cancer.In the past decades, the discovery of cancer-specific biomarkers and the advancement of DNA technology has greatly aided the molecular characterization of cancers.Improvements in bioimaging techniques and artificial intelligence (AI)-assisted image analysis further improved the precision of cancer diagnosis.Nevertheless, clinical diagnostic technologies used to screen for effective treatment options lagged behind.The hurdles not only lay in the limitation of real-life sample supply for method development, but also in the lack of appropriate models to recapitulate the dynamic in vivo scenario.Furthermore, the lengthy and expensive trials to fulfil the legal requirements of clinical diagnostic tools deters most translational efforts of primitive discoveries.
No takes yet. Share an insight, caveat, or question.
Ada Hang‐Heng Wong (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: